We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current KRKAF market cap is 0. The company's latest EPS is EUR and P/E is N/A.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 1.49B | 1.53B | 1.56B | 1.71B | 1.8B |
Operating Income | 272.86M | 389.79M | 353.63M | 379.48M | 397.65M |
Net Income | 245.55M | 291M | 309.21M | 363.3M | 313.95M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 2.18B | 2.24B | 2.54B | 2.69B | 2.76B |
Total Liabilities | 517.1M | 483.73M | 618.6M | 548.99M | 582.53M |
Total Equity | 1.67B | 1.75B | 1.92B | 2.14B | 2.18B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | 349.52M | 360.76M | 386.1M | 467.65M | 227.25M |
Investing | -124.81M | -109.59M | -372.64M | 76.41M | -343.24M |
Financing | -124.27M | -154.61M | -169.85M | -187.02M | -229.82M |
Market Cap | 0 |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 32.79M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0 (0%) |
Company Name | KRKA DD (PK) |
Address |
smarjeka cesta 6 novo mesto 8501 |
Website | https://www.krka.si |
Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions